| Date Filed | Type | Description |
| 08/18/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 0% stake in Sutro Biopharma, Inc. |
| 01/06/2021 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 16.5% stake in Allakos Inc. |
| 01/28/2020 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 21.7% stake in Allakos Inc. |
| 01/14/2020 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 0% stake in aTyr Pharma, Inc. |
| 02/12/2019 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 5.3% stake in aTyr Pharma, Inc. |
| 02/12/2019 |
SC 13G
| Alta Partners VIII, L.P. reports a 8.5% stake in Sutro Biopharma, Inc. |
| 11/08/2018 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 3.5% stake in Trevena, Inc. |
| 08/02/2018 |
SC 13D
| Alta Partners VIII, L.P. reports a 27.7% stake in Allakos Inc. |
| 05/31/2018 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 0.3% stake in Applied Genetic Technologies Corporation |
| 02/06/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/29/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/27/2017 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 6.5% stake in ESPERION THERAPEUTICS, INC. |
| 02/08/2017 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 1.5% stake in Neothetics, Inc. |
| 02/12/2016 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 0% stake in ZAFGEN, INC. |
| 02/12/2016 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 3.8% stake in Kite Pharma, Inc. |
| 02/12/2016 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 8.7% stake in Neothetics, Inc. |
| 02/12/2016 |
SC 13G
| Alta Partners VIII, L.P. reports a 7.5% stake in ATyr Pharma, Inc. |
| 06/09/2015 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 10.6% stake in ZS Pharma, Inc. |
| 06/03/2015 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 11.7% stake in ZS Pharma, Inc. |
| 04/20/2015 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 6.9% stake in Applied Genetic Technologies Corporation |
| 02/20/2015 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 8.9% stake in Esperion Therapeutics, Inc. |
| 02/12/2015 |
SC 13G
| Alta Partners VIII, L.P. reports a 7% stake in KITE PHARMA, INC. |
| 02/12/2015 |
SC 13G
| Alta Partners VIII, L.P. reports a 19.2% stake in NEOTHETICS, INC. |
| 02/12/2015 |
SC 13G
| Alta Partners VIII, L.P. reports a 5.1% stake in ZAFGEN, INC. |
| 12/15/2014 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 11.7% stake in Trevena, Inc. |
| 11/19/2014 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 9.2% stake in Applied Genetic Technologies Corporation |
| 10/22/2014 |
SC 13D/A
| Alta Partners VIII, L.P. reports a 13.4% stake in Esperion Therapeutics, Inc. |
| 08/08/2014 |
SC 13D
| Alta Partners VIII, L.P. reports a 14.9% stake in Immune Design Corp. |
| 07/03/2014 |
SC 13D
| Alta Partners VIII, L.P. reports a 15.7% stake in ZS Pharma, Inc. |
| 04/11/2014 |
SC 13D
| Alta Partners VIII, L.P. reports a 21.2% stake in Applied Genetic Technologies Corporation |
| 02/18/2014 |
SC 13D
| Alta Partners VIII, L.P. reports a 15.1% stake in Trevena, Inc. |
| 07/11/2013 |
SC 13D
| Alta Partners VIII, L.P. reports a 14.5% stake in Esperion Therapeutics, Inc. |
| 02/01/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|